Horses

Therapeutic Class

Diseases

Flu Avert® I.N. Vaccine



Equine Influenza

Read More:
Best Defenses Against Equine Influenza


Description
Flu Avert® I.N. Vaccine is a unique, proprietary, intranasal, modified-live equine influenza vaccine proven by challenge studies to be safe and effective against North American and Eurasian strains of the equine influenza virus. It was the first intranasal equine influenza vaccine commercially available in the U.S. that has been proven effective against equine influenza viral infection in a challenge model. Flu Avert® I.N. Vaccine showed significant protection from severe viral exposure and was efficacious against respiratory isolates of equine influenza (KY98).

Indications
For the vaccination of healthy horses, 11 months of age or older, as an aid in the reduction of clinical disease and viral shedding caused by equine influenza viruses of both the American and Eurasian lineages.

Caution
Keep refrigerated at a temperature between 35o and 45oF (2o-7oC). Store out of direct sunlight. Use the entire contents of the vaccine after reconstitution. Do not vaccinate pregnant animals. Do not vaccinate within 21 days before slaughter. Burn containers after use. In rare instances, reactions may occur due to unusual sensitivity following the administration of vaccines. In such cases, administer epinephrine as an antidote. We recommend that the vaccine be administered by a veterinarian or a trained technician. A small number of horses may experience mild post-vaccination side effects including slight nasal discharge. These signs should clear in a few days without additional treatment. If you have questions call 1-800-441-8272.

NOTE: A new applicator should be used to vaccinate each horse. No needles are necessary to administer the vaccine. This vaccine is NOT intended for intramuscular or subcutaneous injection. For primary immunization, a single dose is required in horses 11 months of age or older. Horses vaccinated at less than 11 months of age should be given a dose of the vaccine at age 11 months. Revaccination every six months is recommended. Horses at high risk of exposure may benefit from revaccination every three months.

Supplied
10 vials (1 dose each) of lyphilized vaccine
10 vials (1mL) of sterile diluent and 10 nasal applicators
Code: 0011968

Product Label(s) and MSDS

For more information about Merck Animal Health Products call 1-800-441-8272.

To learn more click here